Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nikolay Yu. Sokolov
Observed names:
N. Yu. Sokolov,
Nikolay Sokolov,
Nikolay Yu Sokolov
Institutions:
Russian Cancer Research Center NN Blokhin,
Ministry of Health of the Russian Federation,
Botkin Hospital
Observed institutions:
Russian Cancer Research Center NN Blokhin,
Ministry of Health of the Russian Federation,
Botkin Hospital,
City Clinical Hospital,
Central Clinical Hospital
ORCID:
0000-0002-0316-5156
Observed ORCID:
0000-0002-0316-5156
OpenAlex ID:
A5035987026
Results of the use of an integrated risk scale for postoperative complications in patients with colorectal cancer
2024
·
A. V. Shabunin
, Z. A. Bagatelia
, et al.
·
Surgery and Oncology
·
5
Current Understanding of Antitumor Immunity
2015
·
I. Zh. Shubina
, A. V. Sergeev
, et al.
·
Russian Journal of Biotherapy
·
5
PDF
Perioperative chemotherapy in the treatment of locally advanced forms of colon cancer: literature review
2022
·
A. V. Shabunin
, D. N. Grekov
, et al.
·
Surgery and Oncology
·
2
PDF
Tumor Microenvironment in Neuroblastoma and Immunotherapeutic Approaches: Towards More Effective Treatment
2026
·
Irina Zh Shubina
, Chi-Bao Bui
, et al.
·
Cancers
·
1
PDF
Multidisciplinary approach in treatment of a patient with locally advanced renal cancer and critical coronary artery disease: clinical case
2025
·
Z. A. Bagatelia
, D. N. Grekov
, et al.
·
Cancer Urology
·
1
PDF
Assessing the efficacy of ALK inhibitors in ALK-positive non-small cell lung cancer: A real-world data analysis.
2025
·
Daniil Stroyakovskiy
, Polina Shilo
, et al.
·
Journal of Clinical Oncology
·
1
Real-world data on the treatment of patients with ROS1-positive non-small cell lung cancer.
2025
·
Daniil Stroyakovskiy
, Polina Shilo
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Adjuvant abemaciclib in pN2-3 patients with HR+/HER2− early breast cancer: Real-world outcomes from Moscow centers.
2026
·
Katerina Grechukhina
, Dmitriy Popov
, et al.
·
Journal of Clinical Oncology
Phase 2 study of combined therapy FOLFOX with dabrafenib and cetuximab/panitumumab as first-line treatment for patients with metastatic colorectal cancer MSS with BRAF V600E mutation.
2026
·
Mikhail Fedyanin
, Evgenia Kuzmina
, et al.
·
Journal of Clinical Oncology
PDF
Multicenter, nonrandomized clinical trial to evaluate the efficacy and toxicity of a combination of targeted therapy and chemotherapy in the second-line treatment of patients with metastatic inoperable colorectal cancer.
2026
·
Mikhail Fedyanin
, Evgenia Kuzmina
, et al.
·
Journal of Clinical Oncology
PDF
Stenting or gastroenterobypass anastomosis for tumor stenosis of the gastric outlet: selection criteria and experience of S.P. Botkin Moscow Regional Clinical Research Center
2026
·
Aleksey V. Shabunin
, Aleksandr V. Klimashevich
, et al.
·
University proceedings Volga region Medical sciences
Adjuvant abemaciclib outcomes in routine clinical practice (experience of several Moscow centers).
2025
·
Katerina Grechukhina
, Margarita Sukhova
, et al.
·
Journal of Clinical Oncology
PDF
Trastuzumab deruxtecan (T-DXd) in HER2-positive advanced breast cancer (ABC) with active CNS metastases: Real world data.
2025
·
Lyudmila Zhukova
, Irina Bykonya
, et al.
·
Journal of Clinical Oncology
Antitumor Immunotherapy: Effect of COVID-19 in Cancer Patients
2022
·
Irina Zh. Shubina
, Irina O. Chikileva
, et al.
·
Interdisciplinary cancer research
Antitumor immunotherapy and COVID-19 in cancer patients
2022
·
E. A. Pogodina
, I. Zh. Shubina
, et al.
·
Russian Journal of Biotherapy
Show more works
View as search
Works count:
15
Citation count:
16
H-index:
2
I10-index:
Year
Topic
Type